Growth in Diagnostic Labs and Hospitals Drives IHC Adoption Across Asia Pacific
The Asia Pacific immunohistochemistry market size was valued at USD 531.20 million in 2024. It is projected to grow from USD 576.24 million in 2025 to USD 1,218.85 million by 2034, exhibiting a CAGR of 8.7% during 2025–2034.This growth is attributed to the increasing prevalence of chronic diseases, particularly cancer, advancements in diagnostic technologies, and rising healthcare...
0 Comments 0 Shares 146 Views 0 Reviews